Cell reprogramming could make tumors more responsive to immunotherapy

AI Summary

An international study led by Lund University found in mouse experiments that reprogrammed cancer cells can help organize immune responses within tumors. The findings may inform approaches to make tumors more responsive to immunotherapy, but further research is needed to establish benefits for patients.

In a new international study led by Lund University in Sweden, researchers have uncovered how reprogrammed cancer cells can help orchestrate the immune system's attack on tumors. Experiments in mice revealed how immune cells are recruited and organized within tumors to mount an immune response. The findings could pave the way for more effective immunotherapy and, ultimately, help more patients benefit from the treatment.